#9450
Strongyloïdes
ratti IgG ELISA
ELISA kit for the diagnosis of human strongyloidosis
Lot 2301S (Expiry date : 04.09.2024)
Production date : 05.01.2023
Results of quality control 1 (after
production), date: 12.01.2023
No serum blank (average) : 0.131
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
0.005 |
-0.005 |
-0.001 |
0.001 |
0.000 |
0 |
Negative control serum
(N° 9450-06) |
0.099 |
0.085 |
0.105 |
0.100 |
0.097 |
4 |
Weak positive serum
(N° 9450-07) |
0.857 |
0.824 |
0.828 |
0.838 |
0.837 |
36 |
Positive control serum
(N° 9450-08) |
2.271 |
2.421 |
2.271 |
2.454 |
2.354 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 9450-08 |
> 1.200 |
2.354 |
Yes |
Absorbance of weak positive serum 9450-07, as % of positive
serum |
> 18 % |
36 % |
Yes |
Absorbance of negative serum 9450-06, as % of positive serum |
< 10 % |
4 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.131 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bâtiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|